Operating Margin of Kymera Therapeutics, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Kymera Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Kymera Therapeutics, Inc. Operating Margin for the quarter ending 31 Dec 2025 was -891%, a 60% decline year-over-year.
  • Kymera Therapeutics, Inc. annual Operating Margin for 2025 was -891%, a 60% decline from 2024.
  • Kymera Therapeutics, Inc. annual Operating Margin for 2024 was -556%, a 164% decline from 2023.
  • Kymera Therapeutics, Inc. annual Operating Margin for 2023 was -211%, a 39% increase from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Kymera Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -891% -335% -60% 01 Oct 2025 31 Dec 2025
Q3 2025 -760% -531% -232% 01 Jul 2025 30 Sep 2025
Q2 2025 -698% -488% -233% 01 Apr 2025 30 Jun 2025
Q1 2025 -472% -248% -111% 01 Jan 2025 31 Mar 2025
Q4 2024 -556% -345% -164% 01 Oct 2024 31 Dec 2024
Q3 2024 -229% +166% +42% 01 Jul 2024 30 Sep 2024
Q2 2024 -210% +124% +37% 01 Apr 2024 30 Jun 2024
Q1 2024 -224% +139% +38% 01 Jan 2024 31 Mar 2024
Q4 2023 -211% +134% +39% 01 Oct 2023 31 Dec 2023
Q3 2023 -395% -54% -16% 01 Jul 2023 30 Sep 2023
Q2 2023 -333% -86% -35% 01 Apr 2023 30 Jun 2023
Q1 2023 -364% -169% -86% 01 Jan 2023 31 Mar 2023
Q4 2022 -344% -206% -149% 01 Oct 2022 31 Dec 2022
Q3 2022 -341% -228% -202% 01 Jul 2022 30 Sep 2022
Q2 2022 -247% -156% -172% 01 Apr 2022 30 Jun 2022
Q1 2022 -195% -97% -99% 01 Jan 2022 31 Mar 2022
Q4 2021 -138% -2% -1.5% 01 Oct 2021 31 Dec 2021
Q3 2021 -113% 01 Jul 2021 30 Sep 2021
Q2 2021 -91% 01 Apr 2021 30 Jun 2021
Q1 2021 -98% 01 Jan 2021 31 Mar 2021
Q4 2020 -136% 01 Oct 2020 31 Dec 2020

Kymera Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2025 -891% -335% -60% 01 Jan 2025 31 Dec 2025
2024 -556% -345% -164% 01 Jan 2024 31 Dec 2024
2023 -211% +134% +39% 01 Jan 2023 31 Dec 2023
2022 -344% -206% -149% 01 Jan 2022 31 Dec 2022
2021 -138% -2% -1.5% 01 Jan 2021 31 Dec 2021
2020 -136% +1302% +91% 01 Jan 2020 31 Dec 2020
2019 -1438% 01 Jan 2019 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.